News
An early study hints at an intriguing possibility: The weight-loss drug Ozempic might allow people newly diagnosed with Type 1 diabetes to drop their daily insulin shots.
Ozempic-style drugs treat type 1 diabetes, not only type 2, study finds. Jennifer Zieba. Wed, July 2, 2025 at 9:00 PM UTC. When you buy through links on our articles, Future and its syndication ...
In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...
Initially approved to treat Type 2 diabetes, Ozempic and Mounjaro also can help people with Type 1 diabetes lose weight and control their blood sugar levels, a new study finds.
Patients with type 1 diabetes could possibly cease daily insulin injections thanks to the “miracle” weight loss drug Ozempic originally developed to combat type 2 diabetes, Metro News reported ...
By Meg Tirrell, CNN (CNN) — A weekly dose of semaglutide, the key ingredient in blockbuster medications Ozempic and Wegovy, helped seven out of 10 patients newly diagnosed with type 1 diabetes ...
Treating newly diagnosed type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin.
Semaglutide (known by its brandname Ozempic) has gained widespread attention for its weight loss benefits, but is officially approved for managing type 2 diabetes. While there is currently limited ...
GLP-1 agonists, including liraglutide, are typically used to control blood sugar levels in type 2 diabetes and to promote weight loss. These drugs mimic a hormone released after eating, helping to ...
Type 1 and type 2 diabetes are driven by very different mechanisms. In type 2 , cells in the pancreas that make insulin become less sensitive to blood sugar and produce less insulin in response.
An early study hints at an intriguing possibility: The weight-loss drug Ozempic might allow people newly diagnosed with Type 1 diabetes to drop their daily insulin shots.
Ozempic-style drugs treat type 1 diabetes, not only type 2, study finds. News. By Jennifer Zieba published 2 July 2025 A clinical trial for semaglutide, the active ingredient in Ozempic, found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results